Evaluating polyethylene, polyether-ether-ketone, and metal-on-metal locking mechanism survival in Modular Universal Tumour and Revision System knee reconstructions for oncological indications : insights from the MUTARS Orthopedic Registry Europe.

IF 4.9 1区 医学 Q1 ORTHOPEDICS
Richard E Evenhuis, Michaël P A Bus, Joao van Nes, Sebastian G Walter, Jorge Cabrolier, Marta Fiocco, Robert J P van der Wal, Demien Broekhuis, Simen Sellevold, Michiel A J van de Sande
{"title":"Evaluating polyethylene, polyether-ether-ketone, and metal-on-metal locking mechanism survival in Modular Universal Tumour and Revision System knee reconstructions for oncological indications : insights from the MUTARS Orthopedic Registry Europe.","authors":"Richard E Evenhuis, Michaël P A Bus, Joao van Nes, Sebastian G Walter, Jorge Cabrolier, Marta Fiocco, Robert J P van der Wal, Demien Broekhuis, Simen Sellevold, Michiel A J van de Sande","doi":"10.1302/0301-620X.107B2.BJJ-2024-0623","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Over time, the locking mechanism of Modular Universal Tumour and Revision System (MUTARS) knee arthroplasties changed from polyethylene (PE) to polyether-ether-ketone Optima (PEEK) and metal-on-metal (MoM) in an attempt to reduce the risk of mechanical failure. In this study, we aimed to assess the cumulative incidence of locking mechanism revision for symptomatic instability by type of material, and assess potential associated risk factors.</p><p><strong>Methods: </strong>The MUTARS Orthopaedic Registry Europe was used for a retrospective review of 316 patients (54% male (n = 170), median age 44 years (IQR 23 to 61)) who underwent a MUTARS knee arthroplasty for oncological indications between December 1995 and January 2023. The minimum follow-up was 12 months, and the median follow-up was 7.9 years (IQR 3.3 to 13.0). A competing risk model was used to estimate the cumulative incidence of first locking mechanism revision with death and revision for any other reason as competing events. Possible risk factors were assessed employing a univariate cause-specific hazards regression model.</p><p><strong>Results: </strong>Symptomatic instability of the hinge or locking mechanism due to wear (n = 20) or breakage (n = 14) occurred in 34 patients (11%): 9% of PE (n = 4/45), 20% of PEEK (n = 9/44), and 9% of MoM locking mechanisms (n = 21/227). The cumulative incidences of revision for instability due to wear or locking mechanism breakage at two, five, and ten years were 0%, 5% (95% CI 1 to 15), and 5% (95% CI 1 to 15) for PE, 5% (95% CI 1 to 14), 14% (95% CI 5 to 26), and 16% (95% CI 7 to 29) for PEEK, and 0%, 3% (95% CI 1 to 6), and 10% (95% CI 5 to 16) for MoM. With PE as the reference category, the cause-specific hazard ratio for PEEK and MoM were 3.6 (95% CI 1.1 to 11.9; p = 0.036) and 3.2 (95% CI 1.1 to 9.5; p = 0.043), respectively. Age, BMI, resection length, and extra-articular resections were not associated with the time to locking mechanism revision.</p><p><strong>Conclusion: </strong>Alterations in prosthetic materials have not decreased the revision risk for locking mechanism failure. Besides locking mechanism material, no other patient- or prosthesis-related risk factors for locking mechanism failure were identified. Improvement of the locking mechanism is warranted since revision exposes patients to the risk of serious secondary complications.</p>","PeriodicalId":48944,"journal":{"name":"Bone & Joint Journal","volume":"107-B 2","pages":"239-245"},"PeriodicalIF":4.9000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bone & Joint Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1302/0301-620X.107B2.BJJ-2024-0623","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: Over time, the locking mechanism of Modular Universal Tumour and Revision System (MUTARS) knee arthroplasties changed from polyethylene (PE) to polyether-ether-ketone Optima (PEEK) and metal-on-metal (MoM) in an attempt to reduce the risk of mechanical failure. In this study, we aimed to assess the cumulative incidence of locking mechanism revision for symptomatic instability by type of material, and assess potential associated risk factors.

Methods: The MUTARS Orthopaedic Registry Europe was used for a retrospective review of 316 patients (54% male (n = 170), median age 44 years (IQR 23 to 61)) who underwent a MUTARS knee arthroplasty for oncological indications between December 1995 and January 2023. The minimum follow-up was 12 months, and the median follow-up was 7.9 years (IQR 3.3 to 13.0). A competing risk model was used to estimate the cumulative incidence of first locking mechanism revision with death and revision for any other reason as competing events. Possible risk factors were assessed employing a univariate cause-specific hazards regression model.

Results: Symptomatic instability of the hinge or locking mechanism due to wear (n = 20) or breakage (n = 14) occurred in 34 patients (11%): 9% of PE (n = 4/45), 20% of PEEK (n = 9/44), and 9% of MoM locking mechanisms (n = 21/227). The cumulative incidences of revision for instability due to wear or locking mechanism breakage at two, five, and ten years were 0%, 5% (95% CI 1 to 15), and 5% (95% CI 1 to 15) for PE, 5% (95% CI 1 to 14), 14% (95% CI 5 to 26), and 16% (95% CI 7 to 29) for PEEK, and 0%, 3% (95% CI 1 to 6), and 10% (95% CI 5 to 16) for MoM. With PE as the reference category, the cause-specific hazard ratio for PEEK and MoM were 3.6 (95% CI 1.1 to 11.9; p = 0.036) and 3.2 (95% CI 1.1 to 9.5; p = 0.043), respectively. Age, BMI, resection length, and extra-articular resections were not associated with the time to locking mechanism revision.

Conclusion: Alterations in prosthetic materials have not decreased the revision risk for locking mechanism failure. Besides locking mechanism material, no other patient- or prosthesis-related risk factors for locking mechanism failure were identified. Improvement of the locking mechanism is warranted since revision exposes patients to the risk of serious secondary complications.

评估聚乙烯、聚醚醚酮和金属对金属锁定机制在模块化通用肿瘤和修正系统膝关节重建中用于肿瘤适应症的生存:来自MUTARS欧洲骨科注册中心的见解。
目的:随着时间的推移,模块化通用肿瘤和翻修系统(MUTARS)膝关节置换术的锁定机制从聚乙烯(PE)转变为聚醚醚酮Optima (PEEK)和金属对金属(MoM),以降低机械故障的风险。在本研究中,我们旨在评估不同材料类型的锁定机制修正对症状性不稳定的累积发生率,并评估潜在的相关危险因素。方法:对1995年12月至2023年1月期间因肿瘤适应症行MUTARS膝关节置换术的316例患者(54%为男性(n = 170),中位年龄44岁(IQR 23 ~ 61))进行回顾性分析。最短随访时间为12个月,中位随访时间为7.9年(IQR为3.3 ~ 13.0)。使用竞争风险模型来估计首次锁定机制修正与死亡和任何其他原因的修正作为竞争事件的累积发生率。采用单变量病因特异性风险回归模型评估可能的危险因素。结果:34例(11%)患者因磨损(n = 20)或断裂(n = 14)导致铰链或锁定机构出现症状性不稳定,其中PE为9% (n = 4/45), PEEK为20% (n = 9/44), MoM锁定机构为9% (n = 21/227)。在2年、5年和10年期间,因磨损或锁定机构断裂导致的不稳定而进行翻修的累积发生率为PE为0%、5% (95% CI 1 ~ 15)和5% (95% CI 1 ~ 15), PEEK为5% (95% CI 1 ~ 14)、14% (95% CI 5 ~ 26)和16% (95% CI 7 ~ 29), MoM为0%、3% (95% CI 1 ~ 6)和10% (95% CI 5 ~ 16)。以PE为参考类别,PEEK和MoM的病因特异性风险比为3.6 (95% CI 1.1 ~ 11.9;p = 0.036)和3.2 (95% CI 1.1至9.5;P = 0.043)。年龄、BMI、切除长度和关节外切除与锁定机制翻修的时间无关。结论:假体材料的改变并没有降低锁定机制失效的翻修风险。除了锁定机制材料外,没有发现其他与患者或假体相关的锁定机制失效的危险因素。改进锁定机制是必要的,因为翻修暴露了患者严重的继发性并发症的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bone & Joint Journal
Bone & Joint Journal ORTHOPEDICS-SURGERY
CiteScore
9.40
自引率
10.90%
发文量
318
期刊介绍: We welcome original articles from any part of the world. The papers are assessed by members of the Editorial Board and our international panel of expert reviewers, then either accepted for publication or rejected by the Editor. We receive over 2000 submissions each year and accept about 250 for publication, many after revisions recommended by the reviewers, editors or statistical advisers. A decision usually takes between six and eight weeks. Each paper is assessed by two reviewers with a special interest in the subject covered by the paper, and also by members of the editorial team. Controversial papers will be discussed at a full meeting of the Editorial Board. Publication is between four and six months after acceptance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信